The Effect of Intervention With Potassium and/ or Magnesium-enriched Salt on Neurological Performance of Stroke Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02910427|
Recruitment Status : Completed
First Posted : September 22, 2016
Last Update Posted : September 22, 2016
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Other: Regular salt Other: Potassium-enriched salt Other: Potassium and magnesium-enriched salt||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||291 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Outcomes Assessor)|
|Official Title:||The Effect of Intervention With Potassium and/ or Magnesium-enriched Salt on Neurological Performance of Stroke Patients|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Placebo Comparator: Na salt
Other: Regular salt
Participants eat a regular salt diet.
Active Comparator: K salt
Other: Potassium-enriched salt
Participants eat a potassium-enriched salt diet.
Active Comparator: K/Mg salt
potassium and magnesium-enriched salt
Other: Potassium and magnesium-enriched salt
Participants eat a potassium and magnesium-enriched salt diet.
- The modified Rankin scale (mRs) [ Time Frame: 6 months ]
- The National Institute of Health Stroke Scale (NIHSS) [ Time Frame: 6 months ]
- The Barthel index (BI) [ Time Frame: 6 months ]
- The "good neurological performance" [ Time Frame: 6 months ]The "good neurological performance" is defined as those who met all of the following criteria: a score of zero in NIHSS, a score of 100 in BI, and a score of equal to or less than 1 in mRS.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02910427
|Principal Investigator:||Wen-Harn Pan, Ph.D.||Institute of Biomedical Sciences, Academia Sinica|